Who Should Be Sent for Genetic Testing in Hereditary Colorectal Cancer Syndromes?
Authors:
- 10 August 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (23) , 3534-3542
Abstract
Genetic testing is being adopted increasingly to identify individuals with germline mutations that predispose to hereditary colorectal cancer syndromes. Deciding who to test and for which syndrome is of concern to members of the GI oncology community, molecular geneticists, and genetic counselors. The purpose of this review is to help provide guidelines for testing, given that the results influence syndrome diagnosis and clinical management. Although family history may determine whether testing is appropriate and may direct testing to the most informative family member, evolving clinicopathologic features can identify individual patients who warrant testing. Thus, although the usual absence of clinical premonitory signs in hereditary nonpolyposis colorectal cancer (or Lynch syndrome) adds difficulty to its diagnosis, use of the Amsterdam Criteria and Bethesda Guidelines can prove helpful. In contrast, premonitory stigmata such as pigmentations in Peutz-Jeghers syndrome and the phenotypic features of familial adenomatous polyposis aid significantly in syndrome diagnosis. We conclude that the physician's role in advising DNA testing is no small matter, given that a hereditary cancer syndrome's sequelae may be far reaching. Genetic counselors may be extremely helpful to the practicing gastroenterologist, oncologist, or surgeon; when more specialized knowledge is called for, referral can be made to a medical geneticist and/or a medical genetics clinic.Keywords
This publication has 56 references indexed in Scilit:
- Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implicationsEuropean Journal of Human Genetics, 2006
- Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic PolyposisJAMA, 2005
- Mutations Associated with HNPCC Predisposition — Update of ICG‐HNPCC/INSiGHT Mutation DatabaseDisease Markers, 2004
- Practice Parameters for the Treatment of Patients With Dominantly Inherited Colorectal Cancer (Familial Adenomatous Polyposis and Hereditary Nonpolyposis Colorectal Cancer)Diseases of the Colon & Rectum, 2003
- Multiple Approach to the Exploration of Genotype-Phenotype Correlations in Familial Adenomatous PolyposisJournal of Clinical Oncology, 2003
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer DetectionCA: A Cancer Journal for Clinicians, 2001
- Genotype-Phenotype Correlations in Attenuated Adenomatous Polyposis ColiThe American Journal of Human Genetics, 1998
- Attenuated familial adenomatous polyposis (AFAP) a phenotypically and genotypically distinctive variant of FAPCancer, 1995